President Biden’s executive orders and national strategy to contain the COVID-19 pandemic, along with renewed participation in the World Health Organization, offer a comprehensive approach with tremendous promise toward ending the nation’s public health crisis.

The Infectious Diseases Society of America and its HIV Medicine Association strongly endorse the executive order signed by President Biden today requiring face masks on federal property and other areas of federal authority for the next 100 days to prevent the spread of COVID-19.

Plans to significantly accelerate COVID-19 vaccine rollout announced by the Department of Health and Human Services today represent an important step toward controlling the pandemic.

Ten researchers who are exploring the link between an infectious agent and Alzheimer’s disease have each been awarded $100,000 research grants through the IDSA Foundation’s Microbial Pathogenesis in Alzheimer’s Disease Grant program

The current obstacles to swift and widespread COVID-19 vaccine access are impeding control of the pandemic amid soaring rates of infections, illnesses, hospitalizations and deaths and must be addressed effectively and immediately.

The bipartisan bill passed by the House and the Senate and signed by the president provides urgently needed resources to confront COVID-19, funds critical programs across the government in 2021 and offers great hope for recovery from some of the pandemic’s damaging impacts in the year to come.

AABB and the Infectious Diseases Society of America issued today a resource document outlining considerations for clinicians on the use of COVID-19 convalescent plasma under the Emergency Use Authorization granted by the Food and Drug Administration.

“The first Emergency Use Authorization of a vaccine against the novel coronavirus in the United States offers a promising opportunity to reverse the trajectory of the COVID-19 pandemic." Read Full Statement